Table 1.
Clinical characteristics of the study population.
| Variables | Total, n = 100 | Men, n = 46 | Women, n = 54 | p Value |
|---|---|---|---|---|
| Age, years, mean (SD) | 56.9 (14.6) | 60.4 (13.4) | 52.6 (14.7) | 0.011 |
| Age segments, n (%) | ||||
| <40 years | 13 (13.0) | 3 (6.5%) | 10 (18.5%) | 0.141 |
| 40–50 years | 24 (24.0%) | 9 (19.6%) | 15 (27.8%) | |
| 51–60 years | 19 (19.0%) | 9 (19.6%) | 10 (18.5%) | |
| 61–70 years | 21 (21.0%) | 10 (21.7%) | 11 (20.4%) | |
| >70 years | 23 (23.0%) | 15 (32.5%) | 8 (14.8%) | |
| B-SAQ score, mean (SD) | 11.5 (6.2) | 10.1 (6.3) | 12.5 (5.9) | 0.052 |
| IPSS score, mean (SD) | 17.2 (6.9) | 18.6 (7.1) | 16.0 (6.5) | 0.074 |
| S-IPSS score | 8.0 (3.2) | 7.6 (3.3) | 8.3 (3.1) | 0.174 |
| V-IPSS score | 9.2 (5.6) | 11.0 (5.5) | 7.6 (5.2) | 0.003 |
| IPSS severity, n (%) | ||||
| Mild | 7 (7.0) | 2 (4.3) | 5 (9.3) | 0.120 |
| Moderate | 58 (58.0) | 23 (50.0) | 35 (64.8) | |
| Severe | 35 (35.0) | 21 (45.7) | 14 (25.9) | |
| S-IPSS severity, n (%) | ||||
| Moderate | 69 (69.0) | 36 (78.3) | 33 (61.1) | 0.065 |
| Severe | 31 (31.0) | 10 (21.7) | 21 (38.9) | |
| V-IPSS severity, n (%) | ||||
| Moderate | 89 (89.0) | 38 (82.6) | 51 (94.4) | 0.059 |
| Severe | 11 (11.0) | 8 (17.4) | 3 (5.6) |
B-SAQ: Bladder Control Self-Assessment Questionnaire; IPSS: International Prostate Symptom Score; S-IPSS: storage symptoms IPSS; V-IPSS: voiding symptoms IPSS; SD: standard deviation.